Business Healthcare
Dyslipidemia Therapeutics Market is projected to record 2.5% CAGR through 2028
According to a recently released Fact.MR study, revenues from dyslipidemia therapeutics market surpassed US$ 36 billion in 2018. Low-density lipoproteins held approximately two-thirds of revenues from […]